1. Introduction to Cetirizine Hydrochloride Tablets IP 10 mg – Batch Packing Record (BPR):
Cetirizine Hydrochloride Tablets IP 10 mg are film-coated antihistamine tablets commonly used to relieve allergic conditions such as allergic rhinitis, urticaria, sneezing, itching, and watery eyes. Cetirizine Hydrochloride is a second-generation H1-receptor antagonist that helps reduce allergic symptoms by blocking the action of histamine. The Batch Packing Record (BPR) provides a systematic and documented procedure for packaging Cetirizine Hydrochloride Tablets IP in accordance with established Good Manufacturing Practices (GMP) and approved packaging specifications. Each film-coated tablet contains Cetirizine Hydrochloride IP 10 mg with suitable excipients. The packing process includes packaging material dispensing, line clearance, machine setup, blister or strip packing, overprinting, carton packing, shipper packing, and finished product reconciliation. Critical packaging parameters, including sealing temperature, machine speed, leak testing, environmental conditions, and printed information, are monitored to maintain packaging integrity and product quality. The BPR also includes in-process quality checks, rejection analysis, material reconciliation, yield calculation, and verification by Production and Quality Assurance personnel. The prescribed storage condition is below 30°C, protected from moisture. This comprehensive documentation ensures traceability, packaging accuracy, regulatory compliance, and consistent product quality throughout the packaging operation.
Skip to PDF content2. Flow Diagram – Packaging Process of Cetirizine Hydrochloride Tablets IP 10 mg:
The flow diagram illustrates the systematic packaging process of Cetirizine Hydrochloride Tablets IP 10 mg, highlighting essential operational stages, in-process quality checks, and documentation requirements in accordance with Good Manufacturing Practices (GMP). The packaging process begins with the dispensing and verification of packaging materials, followed by line clearance to ensure the packing area and equipment are clean and free from previous product materials. Subsequently, machine setup and inspection are performed before initiating blister or strip packing operations.
During packaging, critical parameters such as sealing temperature, machine speed, leak test results, packaging integrity, and environmental conditions are monitored to maintain product quality. After primary packaging, approved blister or strip packs undergo overprinting verification, cartoning, and shipper packing according to the specified packing configuration. The process concludes with finished product reconciliation, rejection analysis, yield verification, and Quality Assurance review. Accepted finished products are transferred for storage below 30°C, protected from moisture. This structured packaging workflow ensures product identification, traceability, packaging accuracy, contamination prevention, and compliance with approved Batch Packing Record (BPR) requirements.
3. Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Cetirizine Hydrochloride Tablets IP 10 mg:
The Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Cetirizine Hydrochloride Tablets IP 10 mg are essential for maintaining product quality, packaging integrity, and compliance with Good Manufacturing Practices (GMP). During the packaging process, important process parameters include packaging material verification, machine setup, forming and sealing temperatures, machine speed, overprinting accuracy, and environmental conditions. These parameters must be monitored and controlled within approved specifications to prevent packaging defects. The major quality attributes include tablet appearance, blister or strip seal integrity, correct product identification, legible batch coding, accurate carton filling, and proper shipper packaging. Leak testing and in-process inspections help identify defective packs, missing tablets, damaged packaging materials, and printing errors.
Packaging material reconciliation, rejection analysis, and finished product yield verification provide additional assurance of process control and batch traceability. Quality Assurance (QA) personnel verify compliance with approved procedures and review packaging documentation before batch release. Effective monitoring of CPPs and CQAs helps ensure that Cetirizine Hydrochloride Tablets IP 10 mg remain properly identified, protected from moisture, and packaged consistently according to approved Batch Packing Record requirements.
Note: Specific CPP classifications, operating ranges, and CQA acceptance limits must be established through approved specifications, validation, and quality risk assessment.